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Abstract
Background: The convolution approach to thyroid time-activity curve (TAC) data
fitting with a gamma distribution convolution (GDC) TAC model following bolus
intravenous injection is presented and applied to 99mTc-MIBI data. The GDC model is
a convolution of two gamma distribution functions that simultaneously models the
distribution and washout kinetics of the radiotracer.
The GDC model was fitted to thyroid region of interest (ROI) TAC data from 1 min per
frame 99mTc-MIBI image series for 90 min; GDC models were generated for three
patients having left and right thyroid lobe and total thyroid ROIs, and were contrasted
with washout-only models, i.e., less complete models. GDC model accuracy was tested
using 10 Monte Carlo simulations for each clinical ROI.
Results: The nine clinical GDC models, obtained from least counting error of counting,
exhibited corrected (for 6 parameters) fit errors ranging from 0.998% to 1.82%. The range
of all thyroid mean residence times (MRTs) was 212 to 699 min, which from noise
injected simulations of each case had an average coefficient of variation of 0.7% and a
not statistically significant accuracy error of 0.5% (p = 0.5, 2-sample paired t test). The
slowest MRT value (699 min) was from a single thyroid lobe with a tissue diagnosed
parathyroid adenoma also seen on scanning as retained marker. The two total thyroid
ROIs without substantial pathology had MRT values of 278 and 350 min overlapping a
published 99mTc-MIBI thyroid MRT value. One combined value and four unrelated
washout-only models were tested and exhibited R-squared values for MRT with the GDC,
i.e., a more complete concentration model, ranging from 0.0183 to 0.9395.
Conclusions: The GDC models had a small enough TAC noise-image misregistration
(0.8%) that they have a plausible use as simulations of thyroid activity for querying
performance of other models such as washout models, for altered ROI size, noise,
administered dose, and image framing rates. Indeed, of the four washout-only models
tested, no single model approached the apparent accuracy of the GDC model using only
90 min of data. Ninety minutes is a long gamma-camera acquisition time for a patient,
but a short a time for most kinetic models. Consequently, the results should be regarded
as preliminary.
Keywords: Gamma distribution convolution, 99mTc-hexakis-methoxy-isobutyl-isonitrile,
Thyroid, Time-activity curve, Gamma camera
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Background
The use of technetium-99m hexakis-methoxy-isobutyl-isonitrile (99mTc-MIBI) as a
thyroid and parathyroid imaging agent was first proposed in the late 1980s [1]. Since its
inception, 99mTc-MIBI scintigraphy has been shown to be more accurate and sensitive
than comparable imaging techniques and is currently used to detect and localize differen-
tiated thyroid cancer [2, 3], parathyroid adenoma [1, 4], parathyroid hyperplasia [5, 6],
and parathyroid carcinoma [4, 7].
Several 99mTc-MIBI image acquisition protocols and analysis techniques have been
devised over the last quarter century to aid in the detection of abnormal thyroid and
parathyroid tissue, these include dual-phase scintigraphy [8], factor analysis of a dynamic
scan [9], and time-activity curve (TAC) analysis of a dynamic scan [10]. TAC analysis
provides a means of differentiating between normal and abnormal tissues by comparing
of radiotracer uptake and washout in different regions of interest (ROIs). 99mTc-MIBI does
not undergo significant chemical changes in the body and therefore is passively taken up
in the thyroid and parathyroid tissues and is cleared rapidly from the blood [11]. TAC
analysis also has the potential to provide detailed pharmacokinetic information from
ROIs. Pharmacokinetic parameters, such as the tracer mean residence time (MRT) and
elimination half-life can be used to quantify and characterize disease states, which
ultimately may aid in the diagnosis of thyroid and parathyroid disease.
It is a common practice to inject a bolus of a drug into a vein, but to take images or
venous samples elsewhere. Before the time of first arrival of activity in the sampling re-
gion, there is no drug and no signal in that remote site. Most pharmacokinetic bolus
models ignore this initial mixing and are washout-only models having a maximum
amplitude initially. Thus, at the earliest times following a bolus, there is a severe mis-
match between a washout model and the signal it models. Consequently, most of the
routinely used pharmacokinetic models, e.g., classic compartmental washout models,
do a poor job of fitting early-time organ activity [12, 13]. Thus, washout functions do
not fit concentration or time-activity curves well enough to serve as accurate simula-
tion study models. To model the entire TAC accurately, it is necessary to use a math-
ematical model that includes at least some of the drug arrival and organ drug
distribution effects. Convolutions of two functions as an impulse response model can
approximate the entire TAC accurately [14, 15]. Of these two functions, the first or fast
function can be thought of as an organ feed or stimulus function consisting of rapidly
changing blood pool background within the organ. The second can be thought of as
the response or result of bathing the parenchyma of an organ with drug [16, 17].
While there has been some work on the biodistribution and pharmacokinetics of
99mTc-MIBI [18, 19], to the best of our knowledge, there has been no presentation of a
gamma distribution convolution (GDC) model application in the nuclear or pharmaco-
kinetic literature. GDC models have been applied elsewhere for ecological water storage
I/O, waiting times in queueing theory, and in the evaluation of aggregate economic risk
of portfolios [20]. Another possibility would be to construct a convolution model from
observed input and organ functions using multiple ROIs as has been done for the
kidney [16, 21, 22]. However, the advantages of finding a closed form convolution
solution for TAC use, like the GDC model, are that only a single organ ROI is used,
and that long-term data collection, as needed for washout-only modelling, becomes a
shorter term requirement. Finally, unlike convolution methods using observed input
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functions, a closed form convolution is self-contained and thus useful as a surrogate
for otherwise impossible to perform exhaustive testing while still maintaining a degree
of realism.
In this context, we aim to demonstrate that following a peripheral intravenous bolus
injection, the thyroid has a TAC that can be modelled accurately using the closed form
convolution of two gamma distribution (GD) functions. The first GD of the GDC
approximates thyroid gland marker arrival and distribution, and the second GD, the
thyroid marker washout. We apply this model to TAC’s from dynamic 99mTc-MIBI
scans, and show how it can be used to calculate organ statistics, especially MRT values.
Next, we perform a surrogate test example, Monte Carlo simulation of self-consistency
of the GDC algorithm to check the accuracy of modelling. Finally, we compare the
GDC, a more complete model of concentration, to four of the best available washout-
only models for our 90-minute data.
Theory
A convolution of two random variables can be used to form an impulse response model of
time activity of an imaged organ’s radioactivity [14]. The first, fastest random variable is the
impulse or blood pool that feeds the organ, and the second, slower random variable is the
washout of activity from that organ. Note (1) that random variables are modelled as density
functions and add by convolution, (2) that the total area of any density function is one, and
(3) that any convolution of density functions is itself a density function with a total area of
one [23, 24]. Closed form convolutions that model both arrival and washout have also long
been used as pharmacokinetics models as originally inspired by Bateman’s treatment of
radioactive density functions of parent (be− bt) and daughter species (βe− βt) [25]. This latter
is perhaps best written as the exponential density function convolution (EDC)
EDC b; β; tð Þ ¼ be−bt⊗ βe−βt
¼ gbβ e−βt−e−btb−β ; b≠βb2t e−bt ; b ¼ β t≥0




The amount of daughter (or time activity) at time zero, i.e., the initial EDC func-
tional height, is zero in this particular non-negative-valued Bateman equation.
However, when taken out of the parent-daughter decay context, Eq. (1) becomes
only approximate. Generally, whatever an exponential distribution (ED) can model
is typically better modelled by a gamma distribution (GD) [26]. Exponential distri-
butions are not the preferred shapes to explain organ bolus input function shapes,
for which GDs or other functions are more useful [27–29]. To model the pro-
longed washout kinetics, which models are only fit following peak organ activity, GDs,
one of several possible generalizations of EDs, have better fidelity than mono- and bi-
exponential models [12, 13, 30–33]. One reason for this is that GD washout models imply
zero initial drug volume with no initial mixing [33]. Thus, a GD convolution (GDC)
should better fit an organ TAC than Eq. (1), as both the organ delivery and organ washout
are more realistically modelled using GDs than EDs. The b = β solution to Bateman Eq.
(1) can be written as a gamma density; GD(2, b; t) and its nth convolution as GD(n, b; t).
However, b = β is statistically implausible, and n is only ever an integer, thus despite claims
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to the contrary [34], GDs do not derive from serial EDCs. Rather, Eq. (1) is a special case
GD convolution–see the text following Eq. (5), and a derivation of the GD appears
elsewhere [35].
The arrival of the 99mTc-MIBI within the thyroid is not instantaneous. The fast signal
or blood-pool activity within the thyroid is approximated here using a gamma distribu-
tion (GDfast) density function that for time t (min) is time-offset by tΑ ('A' for arrival)
and zero before tΑ by letting τ = t − tA, and setting
GDfast a ; b; τð Þ ¼
ba
Γ að Þ τ
a−1 e−b τ; τ ≥ 0





where, if the dimensionless shape parameter a > 1 would yield a skewed bell curve and
if a < 1 a decaying saw tooth or spike, and where b is the rate scalar (per min).
Washout functions are the impulse response to an instantaneously distributed signal
and strictly washout. A washout function can be modelled as a gamma distribution,
GDWO α; β; τð Þ ¼
βα
Γ αð Þ τ
α−1e−β τ; τ ≥ 0





where α < 1 is the shape parameter condition for washout, i.e., a monotonic decrease
of functional height in time. Next, the GDC model is created by convolving GDfast and
GDWO,
GDC a ; b; α; β; τð Þ ¼ GDfast a; b; τð Þ⊗GDWO α; β; τð Þ; ð4Þ
Substitution of Eqs. (1) and (2) into Eq. (4) leads to
GDC a ; b ; α; β; τð Þ ¼
baβα
Γ aþ αð Þ e
−bτ τaþα−11F1 α; aþ α; b−βð Þτ½ ; τ > 0




which is a density function consisting of a gamma variate multiplied by 1F1(A; B; Z),
where the latter is a confluent hypergeometric function of the first kind1 [36, 37]. For
a = 1 and α = 1, Eq. (5) reduces to Eq. (1), which in turn demonstrates that Eq. (5) is
more general than Eq. (1). That is, in practice, the GDC would reduce to a Bateman
density if a = 1 and α = 1 were plausible parameter values. For b = β, Eq. (5) reduces to
GD(a + α, b; τ), a statistically implausible simplification used nonetheless [34]. Although
serial GD convolution is known [20, 26], the easily recognizable simple closed form for
the two GD convolution of Eq. (5) is a recent development [see [20], Eq. (2)].
Mean residence time, MRT, is independent of any TAC scaling, and its value can be




t f tð Þdt: ð6Þ
MRTs are additive [15]. That is, the mean residence time of the sum of random vari-
ables is the sum of the mean residence times of the random variables.
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However, tracer residence within the thyroid starts at the time of tracer first arrival within
that organ, such that tA is unrelated to thyroid residence time. Moreover, MRTfast ¼ ab
quantifies the delivery and uptake of tracer in the thyroid, and only MRTWO ¼ αβ
relates to how the thyroid washes out of tracer activity once that activity is distributed




The data from three patients were acquired at the Hacettepe University Medical School
and were processed blindly at the University of Saskatchewan. The 99mTc dosages were
740 MBq. Patients 1 and 3 underwent 99mTc-MIBI scanning for metastatic screening,
and were negative. Patient 2 underwent parathyroid scanning for chemical hyperpara-
thyroidism. On scanning, there was 99mTc-MIBI retention in the lower part of the right
thyroid lobe ROI found on histological examination to be a parathyroid adenoma
measuring 11 × 11 mm. The GDC curve analysis was performed blindly and without
knowledge of the region drawing, the scanned images, or the clinical presentation and
results. Clinical correlation was performed only after the quantitative GDC results were
obtained.
Data processing
Following a peripheral intravenous bolus injection, 89 one-minute per frame dynamic
99mTc-MIBI gamma camera images were obtained. Regions of interest (ROIs) were
drawn over the right and left thyroid lobe in each frame, and the regional counts per
minute were then used to construct time-activity curves (TACs). The TACs were then
least Poisson noise model fit with the decay simulated GDC model, Eq. (5)—see the
Appendix section—in a separate institution using Mathematica 10.3 programs using an
algorithm stop condition of a 10-20 relative difference between successive iterations.
Caution was taken to find global minima by including reasonable initial parameter
range, starting values, but there is no absolute guarantee that global minima will be
found with the Nelder-Mead (simplex) regression used. Poisson model noise cal-
culations, regression fitting for Poisson models, corrected fit error quantification,
and an algorithm for finding TAC starting-time values, tA, can be found in the
Appendix section.
Time-activity curve simulations
Monte Carlo simulations were performed for the purpose of estimating how accurate
and precise the GDC results were. The Monte Carlo simulations of each case without
decay correction were performed using each case’s GDC parameters as starting values
to generate TACs. The TACs were then randomized ×10 by injecting pseudorandom
Poisson noise and refit with GDC models using estimated Poisson loss functions to
recover the altered (test) parameters. Unlike for the clinical data, the simulations had
no injected misregistration. Radioactive decay was not simulated in order to (1) partly
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compensate for the lack of injected misregistration by increasing the noise to larger
levels due to generating Poisson model noise from larger, not decay-diminished signals
(2) crosscheck the accuracy of the decay-corrected GDC model used for the clinical
cases, (3) simulate drug assay when decay is not a factor, and (4) provide an example of
how simulations studies can be used to model variations of experimental conditions
and validate techniques.
Washout model analysis with comparison to GDC models
Comparisons of GDC MRTWO results were made to four washout models; two different
regression methods of fitting biexponentials, and two different regression methods of fitting
single gamma variates. One of these latter, Tk-GV; the Tikhonov regularized gamma variate
herein adaptively minimizes the relative error of β or alternatively the minimum relative
error of plasma clearance [12, 13, 32]. Briefly, Tk-GV is an approximate inverse solution to
Eq. (4). That is for C(t) = GDfastTk-GVWO, then Tk-GVWO=GDfast
(−1)⊗C(t), and Tk-GV fits
an inverse (virtual) function, not concentration itself, C(t).
Results
A representative example of a 99mTc-MIBI scintigram from a right thyroid lobe ROI is
shown in Fig. 1a, while the corresponding TAC for the entire dynamic scan is shown in
Fig. 1b. Figure 1c shows the same TAC with time on a logarithmic scale to display the
rapidly changing curve at early times. Superimposed is the fit of the gamma distribution
convolution (GDC) scaled (S) to the TAC. Figure 1d shows graphical representations of
the fast vascular gamma distribution (GDfast), the washout gamma distribution (GDWO)
and GDC; the convolution of GDfast and GDWO.
Figure 2 shows the data and fits of the GDC for all nine TAC’s for the three patients.
The parameter values obtained from fitting the GDC to the TACs and the GDC fit
errors are summarized below in Table 1. The GDC parameters from Table 1 were used
to calculate mean residence times (MRT) for the thyroid ROIs shown in Table 2. Note
in Table 2 that the GDfast, a.k.a., thyroid vascular mixing times, the MRTfast values,
averaged only 0.807 min or 0.2% of the 367.4 min MRTWO, i.e., washout times. MRTfast is
the ratio of the 'a' and b values in Table 1, and is stable even though the shapes
('a' values) of the GDfast distributions are quite variable due to the 'a' and b values
being highly correlated (r = 0.99935). The MRTWO values ranged from 211.6 to
699.0 min. Note that the left lobe, case 2L in Table 2, had the shortest MRT of
only 211.6 min, whereas the same patient’s right lobe, 2R, had the longest MRT
value, 699.0 min.
In addition to the variability of parameters due to divergent kinetics between clinical
cases, there is a lesser amount parameter variability for each case, a.k.a., within case
variability. In order to crosscheck the case-wise accuracy and precision of the fitting
algorithm, Monte Carlo simulations of activity were performed using the observed
clinical parameters values with injected simulated counting (Poisson) noise without
modelling radioactive decay or misregistration. As a result, although there was an
overlap of the fit errors for the simulations versus clinical data, the simulations and
clinical data had borderline significantly different fit error (p = 0.036, from paired
sample two-tailed t testing of Fisher transformed r values). Comparison of the clinical
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GDC parameters to the noise injected recovered parameters allowed for an independ-
ent (if simplistic) measure of accuracy and precision of recovery of the parameters as
listed in Table 3. The recoveries of the start times for simulation, tA, averaged an
insignificant 0.035% error (p = 0.98) suggesting that the start time algorithm of the Ap-
pendix section, Eq. (12), functioned adequately. The mean decay corrected thyroid
washout MRT values went from 367.4 min from the 9 clinical regressions to 369.1 min
from the average of 90 simulations for an absolute error of 0.46%. Note in Table 3 that
none of the GDC simulation MRT values or other parameters (apart from the fit errors
mentioned above) were significantly different from their corresponding clinical
parameter values. Finally, α-shape values were never close to one in the 99 simula-
tions and clinical cases (absolute range from 0.8528 to 0.9445), such that the use
of EDWO = βe
− βt in the Bateman Eq. (1) above rather than GDWO would introduce
severe non-linear misregistration into the data fitting.
From the preceding, the 90 min of data may be sufficient for obtaining a complete
concentration model, the GDC. Next, we tested to see if 90 min was a long enough
time to obtain stable washout-only model MRT values. Table 4 shows a comparison of
the 1st through 89th minute TAC GDC models with 5th through 89th minute TAC
washout models. Two of the four 5th through 89th minute washout models are
Fig. 1 The top left panel (a), shows a region of interest (ROI) drawn over a right thyroid lobe of an example
one-minute image from a 99mTc-MIBI gamma camera image sequence. The top right panel (b) shows the
ROIs time-activity curve (TAC). Panel (c) shows the same right thyroid lobe TAC as in panel (b) with time on a
logarithmic scale to better display the rapidly changing curve at early times. Superimposed is the fit of a gamma
distribution convolution (GDC, solid red line) scaled to the TAC showing a good fit to the TAC (open circles).
Panel (d) shows graphical representations of the GDfast, the fast vascular gamma distribution (F, orange); GDWO,
the washout gamma distribution (W, green) and the GDC; the convolution of GDfast and GDWO (G, blue). For clarity,
the vertical axis has an arbitrary scale to superimpose the GDfast function with the other two functions on one
graph. Note that although the GDWO eventually converges to the GDC model, this takes a long time to occur
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Fig. 2 Shown below are unmodified data and decayed gamma distribution convolution fit results for three patients
their left thyroid lobesⓁ, right thyroid lobesⓇ, and the total summed kilo counts per min for the whole thyroid
glandsⓉ. The small circles are the ROI counts in each one-minute frame for minutes 1 through 89. The solid lines are the
GDC fits of the text. Note the quality of fit, as quantified below (as Fit err % in Table 1). a patient 1 b patient 2 c patient 3
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ordinary least square (OLS) models; biexponential OLS E2 and gamma variate OLS
GV. The other two models are not concentration models. Those are 1/C(t)2 weighted
least squares E2, and the Tk-GV model minimized for least relative error of β; WLS E2
and Tk-GV. For each method, how well the L and R MRT values produced interpolated
total thyroid MRT values was calculated as a coefficient of variation as shown in
Table 4. These CV(interpolation) varied from a high value of 51.9% for OLS E2 to a
low value of 15.9% for GDC. Note that due to patient variation a CV(interpolation) of
zero is not expected. The MRTWO values for OLS E2 were of significantly shorter dur-
ation than those from the GDC model (Wilcoxon, p = 0.004).
As can be seen in Table 4, the smallest and only statistically not significant R2 value
(0.0183, p = 0.7) was between OLS E2 and GDC. The parathyroid adenoma (2R) was
not identified by its MRTWO using OLS E2 and WLS E2, but was the longest MRTWO
for all of the GV-based models and for the GDC model. Although the GV washout
models; OLS GV, Tk-GV, and the average of OLS GV and Tk-GV were superior to E2
models for the single-case lesion detection, the highest R2 value with the GDC of
0.9395 for those washout models occurred for the average MRTWO values of OLS GV
and Tk-GV. This averaged model MRTWO value corresponded to a 10.8% coefficient of
Table 1 Parameters for the GDC fit model
Pt thyroida tA (min) a b (min
−1) α β (min−1) S (106 cts)b Fit err %c Noise % 1 − R2 (%)d
1L 0.195 0.846 0.909 0.8577 0.001849 3.529 1.713 1.174 0.534
1R 0.334 3.733 5.211 0.8661 0.004081 2.319 1.914 1.094 0.350
1T 0.277 1.631 2.060 0.8645 0.003106 5.222 1.421 0.800 0.271
2L 0.340 1.351 1.692 0.9408 0.004445 2.027 1.690 1.183 0.630
2R 0.282 0.995 0.928 0.8668 0.001240 6.510 1.353 1.022 0.395
2T 0.307 1.127 1.203 0.8998 0.002652 6.625 1.019 0.773 0.239
3L 0.306 7.878 11.644 0.8918 0.002029 3.201 1.801 1.225 0.818
3R 0.425 3.082 4.520 0.8942 0.002863 3.296 1.026 1.060 0.189
3T 0.374 6.470 9.842 0.8947 0.002554 6.287 0.988 0.801 0.224
aPatient numbers 1,2,3 plus L left thyroid lobe, R right thyroid lobe, T total thyroid TACs, e.g., 1L, 2L
bS is the scale factor used to equate AUCTAC = S AUCGDC. The AUC of the GDC is one, as it is for all density functions. The
AUC of a TAC is the total counts collected in the ROI from time is zero to infinity
cThe fit error was increased to offset for the effect of using 6 fit parameters in the GDC model—see Eq. (10)
dFrom correlation of the TAC with the GDC model for the 89 one-minute sample times
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variation of root mean square error, CV(rmse), agreement with GDC MRTWO. This
compares to the Monte Carlo testing of the GDC MRTWO, with a 0.69% (CV) for pre-
cision and 0.46% for accuracy—see Table 3.
For the results listed, we processed the TACs as supplied. These neither represented
the values for single thyroid lobes nor for whole thyroid glands but rather a mixture of
Table 3 Poisson noise simulations and accuracy of recovery of generating parameters following
regression
Parameters tA a b α β S
a MRTWO
Units min none min−1 none min−1 106 counts min
Clinical mean values 0.316 3.013 4.223 0.8863 0.00276 4.335 367.4
Simulation mean valuesb 0.316 3.314 4.588 0.8859 0.00275 4.342 369.1
Units Percentage (%)
Mean simulation CV errorc 2.4 0.23 1.6 0.26 3.1 2.6 0.69
Absolute error in percentd 0.035 10.0 8.6 −0.038 −0.38 0.15 0.46
Units Probability
Probability of no differencee 0.98 0.44 0.52 0.32 0.38 0.73 0.51
aThe scale factors S, used to scale GDC, are the total counts collected in the ROI from time is zero to infinity
bEach set of clinical parameters for 9 cases was used to generate 10 different noisy data sets. The simulation mean
values are from all 90 simulations
cThis is the mean value of 9 coefficients of variation (CV), where each CV is from 10 simulations
dError is 100 times mean simulation minus clinical values divided by mean clinical value time
eNo significant differences to the 0.05 level from two-tailed t tests for zero difference between 9 paired samples using
mean values of 10 simulations for each clinical result and the clinical parameter results themselves
Table 4 Mean residence time (MRTWO in minutes) results for simple washout models fit from the
5th to 89th minute ROIs and compared to the gamma distribution convolution (GDC) MRTWO of
the texta
aRegressions used were ordinary least squares (OLS), weighted least squares [WLS; 1/C(t)2 weighting], and an inverse method;
Tk-GV. These were applied to biexponential (E2) and gamma variate (GV) functions. The longest MRT value for each method is in
red. IQR is interquartile range. How well the total (T) thyroid interpolated the L and R MRT values was calculated as a coefficient
of variation of interpolation, CV(interpolation), from the standard deviation of the distances to interpolation, d =MRTTotal −
min{MRTL, MRTR}, divided by the mean of their interpolation interval, ii = |MRTL −MRTR|. The CV of the root mean square error
CV(rmse) was calculated for method M ≠MRTGDC as
Xn
i¼1








. The median of
differences was taken pair-wise. Note that the errors for OLS GV and Tk-GV appear to be, on average, in opposite directions
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those values. For GDC models of whole thyroid glands listed in Table 4, the IQR of
MRT values was 72 min. The GDC IQR from the given mixture of regions was
206 min, and for thyroid lobes without whole thyroid MRT values, the IQR value was
311 min (via Excel PERCENTILE.EXC subtraction or equivalent algorithm).
Discussion
The quality of the fit results illustrated in Fig. 2 and listed in Table 1 suggest that
gamma distribution convolutions, GCDs, can be used to form scaled models that
accurately follow TACs of 99mTc-MIBI activity in the thyroid. A GDC implies two
gamma distributions, GDs: a GDfast delivery to the thyroid function and a slower
GDWO washout from the thyroid function. Note that these separate gamma distribu-
tions were not observed directly, but rather were implied by the thyroid ROI data and
the GDC fitting parameters. To illustrate these behaviours, the individual GDfast,
GDWO, and GDC density functions are displayed in Fig. 1d. That figure shows that the
effect of the GDfast on the GDC dissipated in time, so that eventually the GDWO curve
converges to the path of the data (after ~1 hr). This, and the results in Table 4, confirm
that washout-only models are only indirectly related to TAC or concentration models
[14, 15], and that, in turn explains why washout models appear to require more extended
time-sampling than the GDC model. For example, the GDC residuals were homoscedastic
over the entire sampling space, which is never the case for washout-only models as wash-
out models are at a maximum value initially, when actual concentration is zero. It has
been shown in other systems that washout models, even with a 10 min start time, statisti-
cally significantly mismatched early data and agreed better with late data [12].
Most pharmacokinetic models are thought of as successful when their curve fit
errors average 10% or less [as rmse in 38]. More important than curve fitting
error is how precise the models are for the parameter of interest, or in our case,
MRTWO. We note that no washout model for predicting GDC MRTWO had less than a
10% precision error measured as CV(rmse)—see Table 4—to unequivocally suggest its
use with only 90 min of 99mTc-MIBI data. The average MRTWO for OLS GV and Tk-GV
correlated best to GDC MRTWO. The OLS GV is a direct fit to concentration and Tk-GV
is an inverse solution, virtual concentration fit, and which methods have errors in opposite
directions when applied to only 90 min of data. This combined MRT measurement had
an error of 10.8% compared to the GDC model, i.e., it was almost good enough for clinical
use. Thus, the GDC model may find use as a standard for investigating simpler washout
models. Herein, each OLS model (OLS E2 and OLS GV) was outperformed for
MRTWO R
2 with GDC by its corresponding weighted alternative; WLS E2 and Tk-GV.
Alone amongst the methods tested, MRTWO OLS E2 did not (statistically significantly)
regress or correlate to MRTWO GDC (or to Tk-GV). Better correlated was WLS E2. The
1/C(t)2 least squares weighting fits biexponential washout models favour fitting the later
data to obtain more accurate half-lives [39]. Although some researchers have, without much
discussion, used WLS E2 rather than OLS E2 in their patient series [13, 40, 41], direct
numerical evidence of improved correlation against better or more complete models, such
as that in Table 4, is currently limited. From the Monte Carlo testing—see Table 3—the
GDC MRTWO had a 0.69% (CV) precision and 0.46% accuracy, so that comparison to
GDC as a measure is not obviously error prone.
Wesolowski et al. EJNMMI Physics  (2016) 3:31 Page 11 of 19
No area normalized background subtraction using a second ROI outside of the
thyroid ROI was performed for our analysis. For the current work, background was
considered to be the blood pooling within the thyroid region as modelled by the fast or
delivery function activity, whose short time-duration (MRTfast in Table 2) agrees in a
general way with the short time that 99mTc-MIBI is known to remain in the blood [11].
The background adjustment herein was to treat the blood pooling in the thyroid ROI
as the delivery vehicle to the extravascular tissue within the same ROI for later
washout. This is similar to the fast decaying quasi-exponential functional treatment of
background for 99mTc-MAG3 renal scintigraphy by the recently developed blood-pool
compensation and modified Patlak-Rutland methods both of which do not use classical
background regions [17, 42–44]. The shape of the fast curve, GDfast, i.e., the individual
'a' values in Table 1 were variable and implied shapes sometimes heavier tailed than
exponential distributions (a < 1), and sometimes lighter-tailed, i.e., closer to normal
distributions (a > 1). It would be remiss to imply that the GDfast curve shape is
accurately captured, i.e., the GDfast shape coefficient, 'a' was quite variable—see Table 1.
The difficulty in quantifying the GDfast shape is likely due to the unavoidable sparseness
of nuclear decay data. Using faster framing rates to capture the shape of the fast
function better would likely increase both misregistration and noise as these measures
covaried (r = 0.77 see Misregistration in the Appendix section). However, the mean
MRTfast times from patient studies, numerically a/b, were quite stable as the 'a' and b
values were highly correlated (r = 0.99934). From the simulations, the mean standard
deviation MRTfast time was only 1.0 s (within cases), where the population standard
deviation (between cases) was 0.137 min (8.2 s) suggesting that two parameter GDfast
functions are adequate for calculating MRTfast values. The washout function, GDWO,
has a shape parameter, α < 1, which yields a curve that is monotonically decreasing
(washing out), with very stable shapes herein [CV(α) = 2.9% from patient studies, 2.6%
from simulations between cases, and 0.26% from simulations within cases]. The rate
scalar (β) of the GDWO is much smaller (i.e., slower) than the rate scalar (b) of the fast
curve. Combined with concentration curves, washout models are used for predicting
clearance, as they conserve mass. However, washout models do not form accurate
models of early time TACs—see Fig. 1d—and [45], and that is a good motive for creat-
ing more complete models, i.e., that better fit the data, with the alternatives being (1)
to ignore the early data, extend the data collection for hours, and to use models whose
misregistration magnifies substantially outside of fit range—see [12, 45], or (2) include
the early data and suffer significant, large misregistration within the fit range—see [12].
Despite the pleomorphic shapes of an assumed fast function, and the noise problem,
the resulting GDC functions’ misregistration of the TACs counts was only 0.80% with a
total fit error of 1.44% (see Misregistration in the Appendix section). Using our thresh-
old measure of goodness-of-fit for curve fit errors of 10%, the GDC TAC error was an
order of magnitude better fitting than most models [38].
MRT values were obtained here without performing absolute uptake calculations,
drawing more than one ROI per thyroid lobe, or acquiring data for a long time, e.g.,
6 h, see [18]. The GDCs models’ decay corrected mean residence times (MRTWO) of
99mTc-MIBI in the thyroid TACs ranged from 211.6 to 699.0 min. However, not all of
our results were from region drawing over normal tissue. We observed considerable
differences between the left and right thyroid lobe MRTs, even in our sample of only
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three cases. Patients 1 and 3 had neoplastic disease elsewhere and no thyroidal meta-
static disease detected on scanning. However, patient 2 (2R) had an inferior pole of
right lobe of thyroid region 11 × 11 mm parathyroid adenoma. In diseases such as
hyperparathyroidism and parathyroid adenoma/carcinoma, thyroid metabolism is
presumed normal while the parathyroid tissue is abnormal and typically hyperplastic
hypometabolic (containing enlarged, slow to washout parathyroid glands). Indeed, the
MRT for that entire right lobe was the slowest in this series at 699 min even though
the adenoma was much smaller than the whole ROI. When the patient with thyroid
pathology was excluded, the two remaining total thyroid MRTs had values of 278 and
350 min, or not dissimilar to the published thyroid MRT of 314 min obtained using a
monoexponential washout model and 6 h of imaging data [18]. This blinded study may
have unintentionally detected an adenoma using the GV models. All of the GV models
had their longest values associated with the parathyroid adenoma containing thyroid
lobe TAC. Usually far outliers (>3 IQR) should receive some comment, and this was
the case for OLS GV for the parathyroid adenoma containing thyroid lobe. That GDCs
MRTs are proper measurements is evidenced by (1) the adenoma lobe’s MRT being the
longest GDC-MRT time, (2) having lowest total (T) thyroid MRT value interpolation
error between L and R thyroid lobes,—see Table 4—and (3) the very low misregistration
of the GDC model. However, as the interpatient variation of hot spot MRT values is
unknown this case series is far too small to the established clinical utility for any MRT
calculation. We also perceive a need to establish robustness of the GDC fit algorithm
in the clinical setting and to establish any potential applicability to myriad other thyroid
pathologies for which the visual clues on scanning are not as obvious as for hot spot
imaging. On the other hand, Table 4 shows that the biexponential, OLS E2 and WLS
E2, values (1) failed to identify the adenoma containing thyroid lobe, (2) had poor
quality interpolation results of L and R thyroid lobe MRTs, and (3) had large modelling
errors. Thus, this case series was large enough to demonstrate that the OLS E2 and
WLS E2 models can be problematic for identifying hot spots with only 90 min of data.
Our hypothetical explanation for this failure is that the MRTWO values were
significantly, spuriously, and similarly shortened due to the instant-mixing property of
biexponential models. Instant-mixing range-restricts quantifying redistribution, and
biexponential models borrow from the physical redistribution to make inflated mass
elimination estimates [33]. Moreover, redistribution is the predominate cause of
concentration dilution at early times following bolus delivery [33]. We hypothesize that
physically, redistribution is generalized and similar for L, R, and T and that redistribu-
tion contamination makes the biexponential MRT values too fast and too similar, and
thereby not properly interpolative and consequently non-diagnostic.
In prior works, the kinetic behaviour of 99mTc-MIBI in the thyroid and parathyroid glands
has been extensively explored using semi-quantitative parameters or visual examination of
images acquired at different times [8–10]. Although severely limited by the retrospective na-
ture of the current study, the GDC model should nonetheless allow for a prospective pre-
cise quantitative assessment of disease states using only 90 min of data for pharmacokinetic
parameters such as the MRT, or at very least provides a model of concentration/counting
for simulation studies for the evaluation of washout models of MRT. This case series was
large enough to demonstrate that GDC functions can be of sufficiently high fidelity of fit to
imply the use of GDC functions as templates for pharmacokinetic simulation studies, and
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in that capacity one can consider the results as demonstrating a proof of principle for simu-
lation studies. Indeed, we checked the self-consistency of the clinical decay correction algo-
rithm by comparing its results to the results from simulated data without drug decay.
For washout-only models, one should wait for at least several minutes before starting
the fit of polyexponential washout models, and hours before fitting monoexponential
washout models, and the fitted data should be collected for as many hours as possible.
One alternative to such a fitting strategy is not to attempt to fit concentration itself,
but to fit a different regression target, for example, minimum relative error of the rate
scalar (β), or weighting toward the later time samples. However, we did not have
enough elapsed time for sampling to do this accurately—see the Results section and
Table 4. Our other strategy was to use the GDC; a more complete model from the
addition of random variables, where chained random variables add by convolution. The
use of convolution to create concentration models inclusive of early and late data is
hardly new [15]. However, this has usually been done using sums of exponential terms
for the washout models, which latter are less accurate and precise washout models than
gamma distribution models see Table 4 and [13, 31, 46]. The current work is possibly a
first application of a GDC radioactivity (or concentration) model. Many drugs follow
GD washout curves [31]. GD washout models extrapolate to late time better than
biexponential functions [12], and in their adaptively obtained form from Tikhonov
regularization, as Tk-GV, are less affected by altered body fluid states than exponential
models [32, 47, 48]. Thus, GDC model simulations with altered count rates or injected
noise levels could be used to inspect the effects of altered 99mTc-MIBI dosage, ROI size,
framing rates, or start times for fitting models and regression targets including those
for various washout functions and the GDC models themselves.
The Table 3 summary of Monte Carlo noise simulations illustrates the parameter ac-
curacy one can expect from GDC modelling. The Appendix section Eq. (12) was used
to estimate start times and appears to have functioned properly with very little error on
simulation. The GDfast parameters 'a' and b were somewhat inaccurately recovered fol-
lowing simulation. However, the most important MRTWO results proved to be both ac-
curate (0.46% mean error) and precise (mean CV 0.69%). An accurately determined
parameter was α with a within case accuracy error of −0.038%. This parameter deter-
mines the shape of the washout curve, which is the predominant shape determinant of
the GDC model. This explains the relative superiority of GD washout models to sums
of exponential terms, as the latter have a rigid assumed shape and lack a shape param-
eter. Thus, it should also be possible to use the GDC model to test for the optimal time
to first fit a washout model to a TAC, which given the disagreement between early
activity and the typical washout model functional height, is generally thought to be ≥ 5
min for gamma variate washout model adaptive fitting or polyexponential model fitting
[12, 13, 32] and > 1 h to 6 h, for monoexponential washout model fitting, which latter
cannot be directly compared to the time limited gamma camera data herein [18]. In
summary, what sample times are needed for fitting a washout model to data so that the
parameters obtained are accurate has not been systematically examined, but the
methods herein provide a model that should be useable for that purpose.
One of the limitations of the current retrospective study was that the gamma camera
acquisitions in the parent series were started after tracer first arrival in the thyroid.
However, for the studies processed and for our simulations, a minor delay in the
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acquisition start time proved to be somewhat forgiving—see the Appendix section for
details. Nevertheless, further work on calculating the time of first arrival of activity in the
target organ and examination of a larger patient series may be useful. The GDC model
was processed using 90 min of data, and although the GDC model MRTWO results ap-
peared to be meaningful thyroid/parathyroid measurements, the GDC model as applied
to longer imaging times remains untested. Thus, the conclusions are preliminary.
Conclusions
By using thyroid 99mTc-MIBI scintigraphy data from 3 patients, we generated 9 TACs and
90 Monte Carlo TAC simulations using gamma distribution convolution (GDC) models.
The GDC models fit the TAC data with high fidelity and small enough TAC noise-image
misregistration (0.8%) that they have a plausible use as simulations of thyroid activity for
querying performance of other models, such as washout models, for altered ROI size,
noise, administered dose and image framing rates. Monte Carlo accuracy testing results
for all of the GDC model parameter values were good with a GDC MRT accuracy of
0.46%, despite fitting only 90 min of data. Since the GDC model is an actual concentration
model, it does not have to decay several half-lives in order to obtain model parameters or
validate the methodology. The 4 washout-only models applied to the same data all
exceeded 10% precision error compared to the GDC, with the apparent excess error sus-
pected to be from having insufficient temporal data for washout modelling.
Endnote
1The fast computation of this relies on 1F1 A; B; Zð Þ ¼ Γ Bð ÞΓ B−Að ÞΓ Að Þ
Z 1
0
eZ tuA−1 1−uð ÞB−A−1du,
where A, B, and Z are variables and where the function is finite for all finite values of those
variables. Also, we set GDC(⋅⋅⋅⋅; τ = 0) = 0 to replace the 00indeterminacy of τa + α− 1 at
a + α = 1, τ = 0 with its limiting value of 0.
Appendix
Expected Poisson noise calculation, fitting to minimize the noise of counting, and cal-
culation of fitting error
The expected (Poisson model) noise (N, noise percent, Table 1) from counting increases
as the square root of the number of counts per frame in the ROI, which as a percentage








To scale amplitude of the GDC to the AUC of a TAC, a scale factor S (total counts col-
lected in the ROI from time is zero to infinity, here) is used during the fitting process.
Due to decay, the AUC of total counts is not an AUC of concentration. The fitting param-











where i = 1 − 89 represent each of the 89 one-minute time samples, and the 99mTc
decay rate [49] is λ = ln(2)/[60(min/h) ⋅ 6.0067 (h)] ≈ 0.00192326. Decay correction
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using was performed on the fitted model in order to preserve the noise characteristics
of the observed data during regression analysis. To express Eq. (9) as a goodness-of-fit
containing error that includes that from noise, modelling error of fitting, gamma cam-
era nonlinearity, and patient motion, one computes







where F, the fit error percent in Table 1, from minimization has been augmented to
correct for the m = 6 parameters of the GDC model (five GDC variables and one curve










Assuming counting error of a Poisson noise type, misregistration, an imaging term is
defined graphically as the standard deviation vertical misalignment on a square root of
count rate TAC plot, which latter is, indeed, an image. Misregistration standard
deviation, σM = 0.79943%, was calculated from the well-known equation for correlated
variances
σM
2 ¼ σF ;N 2 ¼ σF 2−σN 2−2ρF;NσFσN ; ð11Þ
where the variance of misregistration, σM
2 , is σF,N
2 , the variance of the difference between
fit error, σF = 1.44164% [from the standard deviation from Table 1 of Eq. (10)], and
noise error, σN = 1.02864% [Eq. (8)], where ρF,N = 0.76531 is the correlation coefficient
of F and N.
Calculation of a stable starting times (tA) for gamma distribution convolutions
The fit parameters a, b, and tA are interrelated making a grid search for tA poorly be-
haved. In practice,tA starting values even a fraction of a minute away from the correct
value can convert the GDfast into a degenerate normal distribution (ND) of the type
lima→∞ GD ¼ ND with either tA→ −∞ or b→∞. This occurs because as the shape par-
ameter 'a' of the fast gamma distribution of Eq. (2) increases, the GDfast mean time in-




=b , and that
produces either a shift of the GDfast curve to later time, or a large negative curve fit tA
start time (an ND starts at t = −∞ and not at t = 0). To avoid this instability, an inde-
pendent method of calculating start times was used. Herein we borrowed an algorithm
from prior work, which suggested that the start time of a rapidly changing in time aor-
tic signal can be calculated from back extrapolation to the activity is zero axis using the
maximum slope of the aortic signal’s 0 to t integral (or more accurately its cumulative
0 to ti sum) [16, 21]. This is because such an integral is monotonically increasing,
which approximately linearizes its early slope, which slope is at a maximum value at
very early times when the activity in the ROI is non-trivial. Using the first two available
samples of the thyroid cumulative sum allow for the calculation of a start time from




ðtA−t1Þ→tA ¼ t1−y1 t2−t1y2 ; ð12Þ
which requires that y1 be non-trivial; it must be selected after tA occurs, and that
y2 > y1, that is, y1 should occur before peak organ activity. For an investigation of
the Eq. (12) algorithm’s precision and accuracy see the Results section Table 3.
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Note that the tA values of Table 1 are framing rate offset. That is, the cumulative
counts during the first minute are nominally assigned an occurrence time of 1 min,
whereas the physical time of occurrence for a linear rate of change of counting during
that minute would occur ½min sooner. That means that the physical start times
occurred at tA − 0.5 min, and the gamma camera acquisitions were begun approxi-
mately 11 s after tracer first appearance in the thyroid. Whereas this guaranteed y1
values to be non-trivial, as required for use of Eq. (12), the second condition for use of
that equation, that y1 should occur before peak organ activity, would be problematic
for a delayed gamma camera start time late by much longer than a few seconds.
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